hiv and harm reduction in prisons - united nations office ... · pdf filehiv and harm...
TRANSCRIPT
School of Public Health and Community Medicine
HIV and Harm Reduction in Prisons
Professor Kate Dolan
Program of International Research and Training
National Drug and Alcohol Research Centre
UNSW, Sydney, Australia
UNODC Scientific Event
Science Addressing Drugs And Health: State of the Art
11 March 2014, Vienna, Austria
Background 10 million prisoners - 3 million remandees in the world
BUT 30 million individuals enter and leave prison - 90% male
Prison populations grew by 25% in the last 15 years
Drug dependence key factor in prison growth
US popn up 13%, prison popn up 33%, PWIDs prisoners up 43%.
1/3 of 200,000 heroin users in US imprisoned annually
60% of PWIDs in a 12-city study been in prison.
Re-incarceration rates very high for PWIDs
In Australia, 84% of PWIDs inmates were re-incarcerated in 2 yrs of
release versus 44% of all prisoners. They had a mean of 5
imprisonments.
Background
HIV is a major health problem for prisons around the world.
Prison settings have characteristics that increase HIV transmission.
HIV, HBV, HCV, TB & mental illness more prevalent in prison
High HIV infection and the over-representation of PWIDs in prisons
combined risk behaviour create a critical public-health issue for
prison authorities.
Unless HIV is controlled in the prison setting it may not be controlled in
broader community of some countries.
Prison settings are a practical point of HIV prevention and treatment
Background Few clear documented cases of HIV transmission in prison
Because it is difficult to gain access and the vast turnover of inmates
HIV transmission does occur in prison, and can be extensive.
HIV prevention programs for prisoners are rare
Prisons are very expensive while HIV programs are not.
the US prison system costs US$74 billion ($25,144 per inmate).
the Australian prison system cost $2.4 billion ($50,874 per inmate).
Hepatitis C and TB are very common in prison populations
Aim
Systematic review of the HIV situation in prisons for all countries on
A. Imprisonment rates
B. HIV prevalence among male, female, PWIDs, MSM, sex workers and
transgender prisoners,
C. HIV transmission and incidence
D. AIDS related mortality
E. Provision of HIV programs
The time period under observation was from January 2008 to April 2013.
Methods
• A multilingual (English, German, Spanish, Croatian, French, Arabic,
Portuguese and Russian) desk review of the literature
• A survey of UN staff and experts
• List of Countries from
http://www.unaids.org/en/regionscountries/countries/
Imprisonment rates from the International centre for prison studies
http://www.prisonstudies.org/info/worldbrief/
Results
We identified 4,640 peer reviewed papers and 8,292 documents (see
figure 1).
Total included documents (N=261)
The Review Procedure
Pee-reviewed
literature
(N=12570), Medline
(N=5194), Web of
Science (N=5001),
Embase (N=2375)
Results from duplicate
removal in each
database (N=6111),
Medline (N=2045), Web
of Science (N=2832),
Embase (N=1234)
Combination of search
results and duplication
removal (N=4640)
Excluded articles
on basis of title
(N=3549),
Abstracts
(N=390), and un-
removed
duplicates
(N=340)
Full text exclusion
(N=305)
Total included
peer-reviewed
paper (N=56)
Documents sent by
UNODC officer
(N=169)
Results of exclusion
due to irrelevant
content or being out of
date (N=92)
Total included
received files
(N=77)
Results of
search in 238
Grey Literature
Databases
(N=8292)
Results after
title exclusion
(N=611)
Total included
Grey
Literature
documents
(N=128)
Total included documents (N=261)
Table 1: Countries with data on imprisonment rates and HIV prevalence and regional
imprisonment rates
HIV prevalence among inmates Imprisonment
rate
No. of
countries
Region
MSM PWIDs Female Male All
1
1
6
6
10
182
20
East/ Southern
Africa
1
2
2
12
68
25
West/Central
Africa
1
5
4
8
129
35
Asia and Pacific
1
332
16 Caribbean
3
6
6
12
220
30 Eastern Europe
and Central Asia
3
4
3
210
17 Latin American*
2
3
4
7
128
21 Middle East and
North African
2
1
1
2
6
127
22 Other Countries
3
9
26
28
58
146
196 Total
Table 2: the percentage of PWIDs in prison populations
Country Past IDU %
Afghanistan 1
Hungary 1
Belgium 2
Kenya 3
Cape Verde 3
Thailand 3
Iran 3 (Females)
Tanzania 6
Netherlands 8
UK 1 - 8
Latvia 9
Brazil 10
Spain 9 - 24
Ukraine 35 - 48
Australia 17 – 68
Table 3: HIV positive in prison populations
East and South Africa %
Mozambique 5- 17
Kenya 6 – 27
Rwanda 6
Ethiopia 7
Uganda 11
South Africa 16
Swaziland 35
Zambia 42
Table 4: HIV positive in prison populations
West and Central African Region
%
Nigeria 2
Cape Verdi 2
Niger 3
Senegal 3
Cote d’Ivoire 4
Mauritania 4
Burkina Faso 5
Cameroon 5-8
Togo 7
DR Congo 8
Ghana 10-20
Table 5: HIV positive in prison populations
Asia and Pacific Region
%
Australia 0
Sri Lanka 0
Pakistan 2
Cambodia 3
Malaysia 6
India 7
Indonesia 7
Vietnam 10
Table 6: HIV positive in prison populations
Eastern Europe and Central
Asia
%
Hungary <1
Azerbaijan 3
Lithuania 4
Russian Federation 4
R. Moldova 5
Kazakhstan 2-6
Latvia 7
Romania 1-10
Estonia 14
Ukraine 10-20
Table 7: HIV positive in prison populations
Latin America Region
%
Chile 2
Argentina 3
Mexico 1- 12
Brazil 6 (males)
Table 8: HIV positive in prison populations
Middle East and North African Region
%
Egypt 0
Iran 0 – 2
Morocco < 1
Oman < 1
Saudi Arabia < 1
Afghanistan 1 – 4
Table 9: HIV positive in prison populations
Other Countries Region
%
Netherlands 0
Hong Kong 1
Luxembourg 1
USA 1 Females
Italy 4
Portugal 6
Spain 6 – 11
Table 10: Injecting and sharing in prison populations and in IDU prisoners
Country % injected % shared
Russia 10 66
Greece 20 83
Greece 24 92
Thailand 25 78
IDU INMATES
Afghanistan 17
Australia 31 70
Scotland 37
Scotland 58
Pakistan 22-70 56
Australia 74 90
Table 11: Outbreaks of HIV transmission in prison populations and in IDU prisoners
Country incidence
Thailand
35/per 100
Lithuania
300 inmates infected in 6 months
Doubled number of HIV cases
Russia
400 inmates infected in a few months
Iran Two outbreaks with hundreds infected
Australia At least 4 up to 12
Scotland 12
Afghanistan 17
Table 12: TB in prison populations
Prevalence
/100,000
MDR- TB % Incidence %
Russia 4,560 12 – 55
Georgia 5,995 13
Azerbaijan, 89
Thailand 568 19
Zambia 4,000 9
Brazil 30
USA 0.4—8
Table 13: Hepatitis C transmission in prison
Location Incidence in PWIDs in prison per 100 person yr
Scotland Taylor 3
US Macalino 5
UK Champion 12
Australia Dolan HITS 34 18 13
Australia Dolan 24 in MMT 32 no MMT
Mortality after prison release
0.95
0.96
0.97
0.98
0.99
1
0 3 6 9 12 15 18 21 24 27 30 33 36
Rate of survival
Left prison on
methadone
Left prison not
on methadone
Table 14. Summary of the number of countries with HIV programs
Region East
Sth
Africa
West
Central
Africa
Asia
Pacific
Caribbean East
Europe
Latin MENA Other Total
No of
countries
20 25 35 16 30 17 21 24 196
NSP 6 1 4 11
OST 5 7 2 10 24
VCT 8 5 13 1 3 8 6 11 65
HIV treat 8 3 8 2 8 4 8 41
STI 5 1 9 1 6 1 4 7 34
Condoms 6 3 7 7 1 5 29
IEC 8 3 10 1 12 6 5 9 54
Prevent,
treat
Hepatitis
8 1 4 11 2 4 16 42
TB 8 3 7 1 11 6 2 4 42
Evaluations of harm reduction in prison
Positive evaluations have been documented for all programs
Condoms – decrease in unsafe sex
OST– decrease in injecting and sharing , trend to decrease HCV
NSP – decrease in injecting and sharing, no HIV/ HCV transmission
HIV education – improved knowledge
Recommendations
Good prisoner health is good public health: High turnover of inmates
mean diseases contracted inside leave prison.
Start and continue ARV and TB treatment is essential to prevent HIV
drug resistance and MDR-TB.
Reduce prison populations: Provide OST also stops mortality. Divert
drug offenders to treatment whenever possible. Provide NSP and
condoms to reduce HIV transmission in prison.
Prisoners have a legal right to medical treatment same level as in the
community.
Compassionate release from prison should be available to inmates in
the final stages of AIDS.
Acknowledgment
Co-authors
Babak Moazen, Atefeh Noori, Shadi Rahimzadeh, Farshad
Farzadfar, Stuart Kinner and Ernie Drucker.